The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Cannabinoids and the gastrointestinal tract
Open accessAbstract
The enteric nervous system of several species, including the mouse, rat, guinea pig and humans, contains cannabinoid CB 1 receptors that depress gastrointestinal motility, mainly by inhibiting ongoing contractile transmitter release. Signs of this depressant effect are, in the whole organism, delayed gastric emptying and inhibition of the transit of non-absorbable markers through the small intestine and, in isolated strips of ileal tissue, inhibition of evoked acetylcholine release, peristalsis, and cholinergic and non-adrenergic non-cholinergic (NANC) contractions of longitudinal or circular smooth muscle. These are contractions evoked electrically or by agents that are thought to stimulate contractile transmitter release either in tissue taken from morphine pretreated animals (naloxone) or in unpretreated tissue (γ-aminobutyric acid and 5-hydroxytryptamine). The inhibitory effects of cannabinoid receptor agonists on gastric emptying and intestinal transit are mediated to some extent by CB 1 receptors in the brain as well as by enteric CB 1 receptors. Gastric acid secretion is also inhibited in response to CB 1 receptor activation, although the detailed underlying mechanism has yet to be elucidated. Cannabinoid receptor agonists delay gastric emptying in humans as well as in rodents and probably also inhibit human gastric acid secretion. Cannabinoid pretreatment induces tolerance to the inhibitory effects of cannabinoid receptor agonists on gastrointestinal motility. Findings that the CB 1 selective antagonist/inverse agonist SR141716A produces in vivo and in vitro signs of increased motility of rodent small intestine probably reflect the presence in the enteric nervous system of a population of CB 1 receptors that are precoupled to their effector mechanisms. SR141716A has been reported not to behave in this manner in the myenteric plexus-longitudinal muscle preparation (MPLM) of human ileum unless this has first been rendered cannabinoid tolerant. Nor has it been found to induce “withdrawal” contractions in cannabinoid tolerant guinea pig ileal MPLM. Further research is required to investigate the role both of endogenous cannabinoid receptor agonists and of non-CB 1 cannabinoid receptors in the gastrointestinal tract. The extent to which the effects on gastrointestinal function of cannabinoid receptor agonists or antagonists/inverse agonists can be exploited therapeutically has yet to be investigated as has the extent to which these drugs can provoke unwanted effects in the gastrointestinal tract when used for other therapeutic purposes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., Compton, D. R., et al. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00109-d · Cited by 2,913 · cited 1×
“It is also noteworthy that the endocannabinoid 2-AG was first isolated from canine small intestine.”
BackgroundSelf-citationSR141716A, a potent and selective antagonist of the brain cannabinoid receptor
Rinaldi-Carmona, M., Barth, F., Héaulme, M., Shire, D., Calandra, B., Congy, C., Martinez, S., Maruani, J., Néliat, G., Caput, D., et al. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00773-x · Cited by 1,757
Pharmacology of cannabinoid CB1 and CB2 receptors
Pertwee, R. G. (1997) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(97)82001-3 · Cited by 1,470
Self-citationCannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741
Self-citationEndocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action
Di Marzo, V., Melck, D., Bisogno, T., & De Petrocellis, L. (1998) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01283-1 · Cited by 712
HU-308: A specific agonist for CB 2 , a peripheral cannabinoid receptor
Hanuš, L., Breuer, A., Tchilibon, S., Shiloah, S., Goldenberg, D., Horowitz, M., Pertwee, R. G., Ross, R. A., Mechoulam, R., & Fride, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14228 · Cited by 571
Self-citationPharmacology of Cannabinoid Receptor Ligands
Pertwee, R. G. (1999) · Current Medicinal Chemistry · doi:10.2174/0929867306666220401124036 · Cited by 526
Self-citationAnandamide Amidohydrolase Activity in Rat Brain Microsomes
Desarnaud, F., Cadas, H., & Piomelli, D. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.11.6030 · Cited by 336
An Amino-terminal Variant of the Central Cannabinoid Receptor Resulting from Alternative Splicing
Shire, D., Carillon, C., Kaghad, M., Calandra, B., Rinaldi-Carmona, M., Fur, G. L., Caput, D., & Ferrara, P. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3726 · Cited by 330
Lynn, A. B., & Herkenham, M. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38654-4 · Cited by 276
The anandamide transport inhibitor AM404 activates vanilloid receptors
Zygmunt, P. M., Chuang, H.-H., Movahed, P., Julius, D., & Högestätt, E. D. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00207-7 · Cited by 270
Structural determinants for recognition and translocation by the anandamide transporter
Piomelli, D., Beltramo, M., Glasnapp, S., Lin, S. Y., Goutopoulos, A., Xie, X.-Q., & Makriyannis, A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.10.5802 · Cited by 268
Expression of the CB1 and CB2 receptor messenger RNAs during embryonic development in the rat
Buckley, N. E., Hansson, S., Harta, G., & Mezey, É. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00348-5 · Cited by 265
Marihuana. Chemistry, Biochemistry, and Cellular Effects.
(1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-6-839_2 · Cited by 210
Preliminary Experiments on the Chemistry and Pharmacology of Cannabis
GILL, E. W., PATON, W. D. M., & PERTWEE, R. G. (1970) · Nature · doi:10.1038/228134a0 · Cited by 210
Self-citationPertwee, R. G. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.7.1553 · Cited by 208
Self-citationThe central neuropharmcology of psychotropic cannabinoids
Pertwee, R. G. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90106-4 · Cited by 178
Self-citationEvidence for the presence of CB2-like cannabinoid receptors on peripheral nerve terminals
Griffin, G., Fernando, S. R., Ross, R. A., McKay, N. G., Ashford, M. L. J., Shire, D., Huffman, J. W., Yu, S., Lainton, J. A. H., & Pertwee, R. G. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01336-8 · Cited by 171
Self-citationFurther evidence for the presence of cannabinoid CB1 receptors in guinea‐pig small intestine
Pertwee, R. G., Fernando, S. R., Nash, J. E., & Coutts, A. A. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15663.x · Cited by 164
Self-citationPertwee, R. G., Stevenson, L. A., Elrick, D. B., Mechoulam, R., & Corbett, A. D. (1992) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1992.tb09088.x · Cited by 159
Self-citationMcCALLUM, SOYKAN, SRIDHAR, RICCI, LANGE, & PLANKEY (1999) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1999.00441.x · Cited by 157
FENESTRATED TRACHEOSTOMY TUBES
LANGE, M. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90918-5 · Cited by 153
In vitro functional evidence of neuronal cannabinoid CB1 receptors in human ileum
Croci, T., Manara, L., Aureggi, G., Guagnini, F., Rinaldi, M. L., Maffrand, J., Fur, G. L., Mukenge, S., & Ferla, G. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702190 · Cited by 150
Coutts, A. A., & Pertwee, R. G. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701301 · Cited by 145
Self-citationInhibitory effect of cannabinoid agonists on gastric emptying in the rat
Izzo, A. A., Mascolo, N., Capasso, R., Germanò, M. P., Pasquale, R. D., & Capasso, F. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900054 · Cited by 130
Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine
Katayama, K., Ueda, N., Kurahashi, Y., Suzuki, H., Yamamoto, S., & Kato, I. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00078-7 · Cited by 128
Morphine-Dependent Rats: Blockade of Precipitated Abstinence by Tetrahydrocannabinol
Hine, B., Friedman, E., Torrelio, M., & Gershon, S. (1975) · Science · doi:10.1126/science.1167428 · Cited by 125
The role of cannabinoid receptors in intestinal motility, defaecation and diarrhoea in rats
Izzo, A. A., Mascolo, N., Pinto, L., Capasso, R., & Capasso, F. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00673-1 · Cited by 115
The effect of cannabinoids on intestinal motility and their antinociceptive effect in mice
CHESHER, G. B., Dahl, C. J., Everingham, M., Jackson, D. M., MARCHANT‐WILLIAMS, H., & Starmer, G. A. (1973) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1973.tb08534.x · Cited by 111
Izzo, A. A., Mascolo, N., Borrelli, F., & Capasso, F. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701964 · Cited by 107
The Pharmacohistory of Cannabis Sativa
Mechoulam, R. (2019) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429260667-1 · Cited by 95
Δ9-Tetrahydrocannabinol inhibits gastric motility in the rat through cannabinoid CB1 receptors
Krowicki, Z. K., Moerschbaecher, J. M., Winsauer, P. J., Sivarao, D. V., & Hornby, P. J. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00165-x · Cited by 94
Izzo, A. A., Pinto, L., Borrelli, F., Capasso, R., Mascolo, N., & Capasso, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703265 · Cited by 93
Psychoactive cannabinoids reduce gastrointestinal propulsion and motility in rodents.
Shook, J. E., & Burks, T. F. (1989) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23416-4 · Cited by 88
Identification and Partial Characterization
Wintroub, B. U., Kaempfer, C. E., Schechter, N. M., & Proud, D. (1986) · Cited by 85
Izzo, A. A., Mascolo, N., Borrelli, F., & Capasso, F. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005325 · Cited by 81
Pertwee, R. G., Fernando, S. R., Griffin, G., Abadji, V., & Makriyannis, A. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(94)00618-h · Cited by 79
Self-citationInhibition of intestinal motility by anandamide, an endogenous cannabinoid.
Calignano, A., La Rana, G., Makriyannis, A., et al. (1997) · PubMed · Cited by 79
Cannabinoid modulation of intestinal propulsion in mice
Colombo, G., Agabio, R., Lobina, C., et al. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)01555-0 · Cited by 78
(1979) · Elsevier eBooks · doi:10.1016/c2013-0-03122-2 · Cited by 75
Effects of SR 141716A after acute or chronic cannabinoid administration in dogs
Lichtman, A. H., Wiley, J. L., LaVecchia, K. L., Neviaser, S. T., Arthur, D. B., Wilson, D. M., & Martin, B. R. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00558-5 · Cited by 72
Heinemann, Á., Shahbazian, A., & Holzer, P. D. (1999) · Neuropharmacology · doi:10.1016/s0028-3908(99)00056-8 · Cited by 69
Modulation of peristalsis by cannabinoid CB1 ligands in the isolated guinea‐pig ileum
Izzo, A. A., Mascolo, N., Tonini, M., & Capasso, F. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703116 · Cited by 63
Anandamide amidohydrolase (fatty acid amide hydrolase)
Ueda, N., & Yamamoto, S. (2000) · Prostaglandins & Other Lipid Mediators · doi:10.1016/s0090-6980(00)00052-6 · Cited by 58
Coruzzi, G., Adami, M., Coppelli, G., Frati, P., & Soldani, G. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900135 · Cited by 58
Nye, J. S., Seltzman, H. H., Pitt, C. G., & Snyder, S. H. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23705-3 · Cited by 54
López‐Redondo, F., Lees, G. M., & Pertwee, R. G. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701393 · Cited by 53
Self-citationComparison of novel cannabinoid partial agonists and SR141716A in the guinea‐pig small intestine
Coutts, A. A., Brewster, N., Ingram, T., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703094 · Cited by 51
Joyce, C. R. B., & Curry, S. H. (1970) · J. & A. Churchill eBooks · Cited by 50
Comparison of cannabinoid binding sites in guinea‐pig forebrain and small intestine
Ross, R. A., Brockie, H. C., Fernando, S. R., Saha, B., Razdan, R. K., & Pertwee, R. G. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702204 · Cited by 49
Self-citationFrederickson, R. C. A., Hewes, C. R., & Aiken, J. W. (1976) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30692-0 · Cited by 48
Evidence for a M1 muscarinic receptor on the endothelium of human pulmonary veins
Walch, L., Gascard, J., Dulmet, É., et al. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703301 · Cited by 44
Costa, B., Vailati, S., & Colleoni, M. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199905000-00009 · Cited by 44
Roth, S. H. (1978) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y78-154 · Cited by 44
Book Review: Cannabis and its Derivatives
Willis, J. (1973) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577306600644 · Cited by 38
Dewey, W. L., Harris, L. S., & Js, K. (1972) · PubMed · Cited by 35
Interaction of Δ9-tetrahydrocannabinol and cannabidiol on intestinal motility in mice
Anderson, P. F., Jackson, D. M., & CHESHER, G. B. (1974) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1974.tb09240.x · Cited by 33
Coutts, A. A., & Pertwee, R. G. (1998) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-76-3-340 · Cited by 32
Self-citationCannabinoid Geometry and Biological Activity
Mechoulam, R., Devane, W. A., & Glaser, R. (1999) · Humana Press eBooks · doi:10.1007/978-1-59259-710-9_9 · Cited by 30
Pravadoline: profile in isolated tissue preparations.
Ward, S. J., Mastriani, D., Casiano, F. M., & Arnold, R. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23062-2 · Cited by 28
Basilico, L., Parolaro, D., Colleoni, M., Costa, B., & Giagnoni, G. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00389-1 · Cited by 23
SR141716A induces in rats a behavioral pattern opposite to that of CB1 receptor agonists.
Costa, B., & Colleoni, M. (1999) · PubMed · Cited by 23
Pertwee, R. G., Browne, S. E., Ross, T. M., & Stretton, C. D. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90366-a · Cited by 21
Self-citationEvaluation of Antiulcer Activity of Δ 9 -Tetrahydrocannabinol in the Shay Rat Test
Sofia, D., Diamantis, W., Harrison, J., & Melton, J. (2008) · Pharmacology · doi:10.1159/000136851 · Cited by 20
Jackson, D. M., Malor, R., CHESHER, G. B., Starmer, G. A., Welburn, P. J., & Bailey, R. C. (1976) · Psychopharmacology · doi:10.1007/bf00735820 · Cited by 17
Delta‐9‐tetrahydrocannabinol and gastric emptying.
Bateman, D. N. (1983) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1983.tb01561.x · Cited by 16
Rivas-Vilchis, J. F., & García, R. (1980) · European Journal of Pharmacology · doi:10.1016/0014-2999(80)90410-0 · Cited by 15
The anandamide transport inhibitor AM404 is an agonist at the rat vanilloid receptor (VR1)
Jerman, J. C., Brough, S., Davis, J. L., Middlemiss, D. N., & Smart, D. (2000) · British Journal of Pharmacology · Cited by 11
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationThe Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 865
Distribution of cannabinoid receptors in the central and peripheral nervous system
Mackie, K. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_10 · Cited by 744
History of Cannabis and Its Preparations in Saga, Science, and Sobriquet
Russo, E. B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790144 · Cited by 621
Metadata
- Authors
- PERTWEE, R. G.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2001-06-01
- Volume
- 48
- Issue
- 6
- Pages
- 859-867
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2157518435
- Cited by
- 326
- References
- 68
- FWCI
- 8.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.